Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative StudyBukstein D, Desai V, Goga L, Brown M, Settipane RA
EAC 2023
Characterizing Attack-Related Health Utility in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
A Systematic Review of Socioeconomic Burden in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future TherapiesSchwander B, Lahue BJ, Cribbs KA, Czado S
ISPOR 2023
Assessing the Burden of Injection with Parenteral Hereditary Angioedema TherapiesSoteres DF, Cribbs KA, Czado S
ISPOR 2023
Rationale for the Short-term Prophylaxis Regimen with Sebetralstat in KONFIDENT-SIverson M, Duckworth E, Hansen E, Hampton SL, Smith MD, Audhya PK, Yea CM
C1 Inhibitor Workshop 2023
HAE Patients Decision to Carry On-demand Treatment When Away from HomeBetschel S, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
C1 Inhibitor Workshop 2023
Route of Administration Preferences of People with Hereditary Angioedema for On-demand Treatment: A US-based Qualitative StudyDesai V, Ledia Goga L, Czado S, Brown M, Myers K, Bukstein D, Audhya PK, Bouillet L
C1 Inhibitor Workshop 2023
Assessing the Potential Benefits of Oral Therapies in Hereditary AngioedemaSoteres DF, Cribbs KA, Guo W, Czado S
AMCP 2023